Contact
Please use this form to send email to PR contact of this press release:
Soleno Therapeutics Announces Top-line Results from Phase III Trial of DCCR for Treatment of Prader-Willi Syndrome
TO:
Please use this form to send email to PR contact of this press release:
Soleno Therapeutics Announces Top-line Results from Phase III Trial of DCCR for Treatment of Prader-Willi Syndrome
TO: